Figure 1From: Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancerOverall survival of the primary surgery group vs. concurrent chemoradiotherapy (CCRT) group. The 5-year overall survival rate was 33% and 44% for primary surgery and definitive CCRT, respectively (p = 0.788).Back to article page